The value of PET/CT for cytoreductive surgery selection in recurrent ovarian carcinoma.
Rafael Leite NunesFlávio Rodrigues TeixeiraThiago Pereira DinizCarlos Chaves FaloppaHenrique MantoanAlexandre Andre Balieiro Anastacio da CostaGlauco BaiocchiPublished in: Journal of gynecologic oncology (2023)
We observed NRD in 92.3% of patients with ≤2 lesions by PET/CT, with an accuracy of 81.2%. PET/CT did not increase the accuracy of the MSK criteria, iMODEL, or AGO score models.